Home LiteratureArticle Details
PMID: 8109945 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.

Antimicrobial agents and chemotherapy ·Vol. 37 ·No. 12 ·1993-12-00 ·Pages 2736-9

French P, Venuti E, Fraimow HS

Abstract

Sixty strains of vancomycin- and ampicillin-resistant Enterococcus faecium were evaluated for their susceptibilities to novobiocin in vitro. In Mueller-Hinton broth, novobiocin inhibited all strains when it was used at a concentration of < or = 2 microgram/ml and 40 of 60 strains when it was used at a concentration of < or = 0.5 micrograms/ml. MICs were 8- to 16-fold higher in 50% serum. Novobiocin alone resulted in 2-log-unit killing at 24 h. Combinations of novobiocin and a fluoroquinolone (either ciprofloxacin or ofloxacin) were additive and bactericidal for quinolone-susceptible strains in either broth or 50% serum. Gentamicin did not affect novobiocin activity, and rifampin and doxycycline were antagonistic.

Related Genes
MeSH Terms
Anti-Infective Agents/pharmacology Ciprofloxacin/pharmacology Drug Interactions Drug Resistance, Microbial/genetics Enterococcus faecium/drug effects,genetics Novobiocin/pharmacology Ofloxacin/pharmacology
Chemicals
Anti-Infective Agents Novobiocin Ciprofloxacin Ofloxacin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
French P
Dorrance H. Hamilton Laboratories, Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania 19107.
Venuti E
Fraimow H S
References (18)
18 references, click to expand
  1. Novobiocin; serum concentrations and urinary excretion following oral administration in man.
    Antibiotic Med Clin Ther (New York). 1956 May;2(5):311-6 PMID: 13314553
  2. The binding of antibiotics to serum proteins.
    Br J Pharmacol Chemother. 1965 Dec;25(3):638-50 PMID: 4958410
  3. Studies on protein binding of antibiotics. IV. Effect of the binding of drug to 100,000 X g supernatant fluid of rabbit liver homogenates on urinary excretion.
    J Antibiot (Tokyo). 1982 Nov;35(11):1603-9 PMID: 7161197
  4. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
    J Antimicrob Chemother. 1986 Jan;17(1):75-82 PMID: 3633267
  5. Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.
    Antimicrob Agents Chemother. 1986 Jul;30(1):42-5 PMID: 3752982
  6. In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.
    Antimicrob Agents Chemother. 1989 Jan;33(1):71-7 PMID: 2496659
  7. Should novobiocin be clinically re-evaluated?
    Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4):363-5 PMID: 2591171
  8. The life and times of the Enterococcus.
    Clin Microbiol Rev. 1990 Jan;3(1):46-65 PMID: 2404568
  9. A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.
    Cancer Res. 1991 Jan 15;51(2):510-3 PMID: 1985770
  10. Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates.
    Antimicrob Agents Chemother. 1990 Sep;34(9):1655-9 PMID: 2285277
  11. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci.
    Clin Infect Dis. 1992 Mar;14(3):655-61 PMID: 1562656
  12. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 1992 Jul;36(7):1563-6 PMID: 1510455
  13. Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s.
    JAMA. 1992 Nov 11;268(18):2563-4 PMID: 1308665
  14. Increasing resistance of enterococci to ciprofloxacin.
    Antimicrob Agents Chemother. 1992 Nov;36(11):2533-5 PMID: 1489199
  15. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC.
    Gene. 1993 Feb 14;124(1):143-4 PMID: 8440477
  16. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.
    Antimicrob Agents Chemother. 1993 Jun;37(6):1334-42 PMID: 8328783
  17. Serious reactions to novobiocin.
    J Pediatr. 1957 May;50(5):579-85 PMID: 13417023
  18. Novobiocin; a limited bacteriologic and clinical study of its use in forty-five patients.
    Antibiotic Med Clin Ther (New York). 1956 Apr;2(4):241-57 PMID: 13303120
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1993-12-00
Pages
2736-9
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC192796
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]